Cargando…
Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
Autores principales: | Harder, Thomas, Koch, Judith, Vygen-Bonnet, Sabine, Külper-Schiek, Wiebe, Pilic, Antonia, Reda, Sarah, Scholz, Stefan, Wichmann, Ole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414955/ https://www.ncbi.nlm.nih.gov/pubmed/34477051 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.35.2100832 |
Ejemplares similares
-
Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021
por: Harder, Thomas, et al.
Publicado: (2021) -
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021
por: Harder, Thomas, et al.
Publicado: (2021) -
Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020) -
Facing the Omicron variant—how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review
por: Külper-Schiek, Wiebe, et al.
Publicado: (2022) -
Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19)
por: Al-Tawfiq, Jaffar A.
Publicado: (2020)